Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
491.47
+26.45 (+5.69%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,918,408
Open
471.64
Bid (Size)
485.45 (40)
Ask (Size)
492.50 (40)
Prev. Close
465.02
Today's Range
471.64 - 503.88
52wk Range
362.50 - 519.68
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026
↗
February 13, 2026
2026 could be a big year for this company.
Via
The Motley Fool
Top S&P500 movers in Friday's session
↗
February 13, 2026
Via
Chartmill
Performance
YTD
+8.7%
+8.7%
1 Month
+9.3%
+9.3%
3 Month
+12.4%
+12.4%
6 Month
+25.1%
+25.1%
1 Year
+6.2%
+6.2%
More News
Read More
Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss)
↗
February 13, 2026
Via
The Motley Fool
Friday's session: top gainers and losers in the S&P500 index
↗
February 13, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Posts Mixed Q4 2025 Results, Provides 2026 Guidance
↗
February 12, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Growth and Breakout Opportunity
↗
February 02, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case
↗
January 29, 2026
Via
Chartmill
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Government
VRTX Q4 Deep Dive: Diversification Beyond Cystic Fibrosis Sets Stage for Next Growth Phase
February 13, 2026
Via
StockStory
Vertex (VRTX) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
Via
The Motley Fool
Topics
Earnings
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue
February 12, 2026
Via
StockStory
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect
February 10, 2026
Via
StockStory
Topics
Artificial Intelligence
World Trade
1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell
↗
February 10, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy Vertex Before Feb. 12?
↗
February 10, 2026
Via
The Motley Fool
Topics
Intellectual Property
Provident Dumps 490,000 MapleBear Shares Worth $18 Million
↗
February 09, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Should You Buy Vertex Pharmaceuticals Before Feb. 12?
↗
February 09, 2026
Via
The Motley Fool
The Bond Market Is Flashing a Clear Warning About the Fed: 3 Stocks to Buy
↗
February 08, 2026
Via
The Motley Fool
Topics
Bonds
Economy
Government
2 Top Healthcare Stocks to Buy in February
↗
February 07, 2026
Via
The Motley Fool
Topics
World Trade
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
3 Market-Beating Stocks Worth Investigating
February 04, 2026
Via
StockStory
Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals
↗
January 29, 2026
Via
The Motley Fool
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
January 28, 2026
Via
StockStory
Topics
Stocks
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
January 23, 2026
From
Equity Insider
Via
GlobeNewswire
Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)
January 21, 2026
Via
StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 491.47
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 02/13/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 127.50B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 128B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.